About Us
THE INTERCEPTOR COST ACTION
Interception of oral cancer development (INTERCEPTOR) COST Action aims to develop a new multidisciplinary approach and to reorganize disease care management by establishing support for people affected by OPMD, which will result in prevention of malignant transformation.
An innovative approach to address the prevention challenges beyond weaning programs and antismoking/ drinking advertising campaigns is foreseen.
Working Groups
WG’S AIMS AND MEMBERS
News & Events
KEEPING YOU UPDATED
Keep up with the latest news,
subscribe our Newsletter
Project information
INTERCEPTOR aims to address the challenge of generating innovative and actionable pathways by engaging with the ‘critical practice’ dimensions of transformation.
A ‘critical practice’ approach explores transformation processes in practice across different dimensions which include research, policy, business, community and individual practices.
Action Contacts
Prof. Pierre Saintigny
Action Chair
+33(0)4 69 85 60 97
pierre.saintigny@lyon.unicancer.fr
Prof. Senada Koljenovic
Action Vice Chair
+31652090524
senada.koljenovic@uza.be
COST Contacts
Dr Rosella Magli
Science Officer
+3225333833
Rossella.Magli@cost.eu
Ms Carmencita Malimban
Administrative Officer
+3225333842
carmencita.malimban@cost.eu
COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. www.cost.eu